Colchicine for narrowed brain arteries after recent stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This Phase 2 trial tests whether colchicine can help people with significant narrowing in brain arteries (from atherosclerosis) after a recent stroke or “mini-stroke.” It aims to reduce the risk related to this condition during the early period after symptoms begin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re Chinese and between 40 and 80 years old
- You had a first-ever ischemic stroke within 8 weeks before joining
- Your brain artery narrowing is at least 50% in specific arteries (middle cerebral or basilar), caused by atherosclerosis
- Your stroke or mini-stroke matched the blood vessel area affected (symptoms in the last 8 weeks)
- You must be able to give informed consent and complete brain scans (CTA/MRI/DSA if needed)
- You must not have conditions that make colchicine unsafe (for example kidney disease, certain blood problems, chronic diarrhea/IBD, colchicine allergy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether colchicine, a medicine that reduces inflammation, can help people recover better and prevent future heart or brain problems after a brain bleed. It may be an option for those with certain health conditions or risk factors.
This trial tests whether taking colchicine (a medicine used for gout and inflammation) after a recent mild or moderate stroke can help prevent another stroke. If it works, it could offer a new way to reduce stroke risk.
This trial tests if colchicine can reduce the risk of another stroke caused by bleeding in the brain due to a condition called cerebral amyloid angiopathy (CAA). You may qualify if you've recently had a brain bleed from CAA and have certain signs on brain scans.
This Phase 3 study tests whether low-dose colchicine added to ticagrelor (a blood-thinning medicine) helps prevent another ischemic stroke in people whose first stroke was caused by clogged arteries. It aims to lower the risk of repeat stroke after recovery from a recent event.
This trial tests whether colchicine (a medicine commonly used for inflammation) can improve how well clogged heart arteries reopen after a short-term heart emergency called ACS. You may be eligible if you’re hospitalized with ACS and are planned for a coronary angiogram and possible angioplasty soon.
This trial tests if the anti-inflammatory drug colchicine can help people with non-severe coronary artery plaque seen on a CT scan. It may be an option if you have stable chest pain or related symptoms and your heart arteries are partly blocked but not severely.
Hear when a new ICAD - Intracranial Atherosclerotic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.